ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2025

Core Viewpoint - ImmuCell Corporation is set to report its unaudited financial results for the quarter and year ended December 31, 2025, on March 4, 2026, with a conference call scheduled for the following morning to discuss these results [1][2][3]. Financial Reporting - The company anticipates no changes to the preliminary sales results disclosed on January 8, 2026, for the quarter and year ended December 31, 2025 [3]. - ImmuCell plans to file its Annual Report on Form 10-K on or before March 31, 2026 [3]. Company Overview - ImmuCell Corporation focuses on developing, manufacturing, and marketing products that enhance cattle health and productivity, including its product First Defense, which provides Immediate Immunity™ to newborn dairy and beef calves [4].